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Background: We carried out a genome-wide study, using microRNA sequencing (miRNA-seq), aimed at identifying
miRNAs in primary sensory neurons that are associated with neuropathic pain. Such scans usually yield long lists of
transcripts regulated by nerve injury, but not necessarily related to pain. To overcome this we tried a novel search
strategy: identification of transcripts regulated differentially by nerve injury in rat lines very similar except for a
contrasting pain phenotype. Dorsal root ganglia (DRGs) L4 and 5 in the two lines were excised 3 days after spinal
nerve ligation surgery (SNL) and small RNAs were extracted and sequenced.
Results: We identified 284 mature miRNA species expressed in rat DRGs, including several not previously reported,
and 3340 unique small RNA sequences. Baseline expression of miRNA was nearly identical in the two rat lines, consistent
with their shared genetic background. In both lines many miRNAs were nominally up- or down-regulated following SNL,
but the change was similar across lines. Only 3 miRNAs that were expressed abundantly (rno-miR-30d-5p, rno-miR-125b-5p)
or at moderate levels (rno-miR-379-5p) were differentially regulated. This makes them prime candidates as novel PNS
determinants of neuropathic pain. The first two are known miRNA regulators of the expression of Tnf, Bdnf and Stat3,
gene products intimately associated with neuropathic pain phenotype. A few non-miRNA, small noncoding RNAs
(sncRNAs) were also differentially regulated.
Conclusions: Despite its genome-wide coverage, our search strategy yielded a remarkably short list of neuropathic
pain-related miRNAs. As 2 of the 3 are validated regulators of important pro-nociceptive compounds, it is likely
that they contribute to the orchestration of gene expression changes that determine individual variability in pain
phenotype. Further research is required to determine whether some of the other known or predicted gene targets of
these miRNAs, or of the differentially regulated non-miRNA sncRNAs, also contribute.
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Neuropathic pain phenotype varies greatly among indi-
viduals even when the underlying pathology is identical.
An explanation of this variability could advance our
understanding of chronic pain and perhaps lead to better
therapeutic options. A key link between nerve pathology
and pain is the response of primary afferent neurons
to axotomy. Nerve trauma induces ongoing pain and* Correspondence: marshlu@mail.huji.ac.il
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unless otherwise stated.hypersensibility by virtue of massive changes in gene
expression that it triggers. Prominent among the resulting
functional outcomes are the emergence of electrical hyper-
excitability and phenotypic switching of neurotransmitter
content [1]. The extent of these changes varies from indi-
vidual to individual. We have tested the hypothesis that
individual differences in neuropathic pain response are
associated with the pattern of up- and down-regulation
of gene expression. The experimental platform used was
a pair of rat lines, HA and LA, that have similar genetic
background and pain response at baseline, but radically
different pain behavior following peripheral nerve injury
[2,3]. Within each line individuals are inbred and hence
genetically identical. But across lines a program of genetic. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain














































































Figure 1 Read counts of small non-coding RNAs in the rat DRG
are skewed to smaller values. (A) Mature miRNAs (n = 284). (B)
Unique sequences of miRNAs and other sncRNAs. RPM values are
based on the three replicate pools of the LA_sham experimental
group (total n ~35 × 106 reads). Distributions for the other three
experimental groups were very similar.
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disposition to pain. Thus, the lines are experimental surro-
gates for two individuals with contrasting pain response.
The inter-line contrast in neuropathic pain behavior in
HA and LA rats is accompanied by appropriately con-
trasting changes in excitability and neurotransmitter
profile [4,5]. Genetic analysis has attributed these differ-
ences largely to polymorphisms at a single quantitative
trait locus (QTL; [6-8]. It is likely, therefore, that the line-
specific pain phenotypes are due to differential regulation
of gene expression following axotomy. However, given
the complexity of pain behavior, it seems doubtful that
regulation of a single gene product is to blame. More likely
is a heritable element capable of controlling the expression
of an entire constellation of functionally-related genes.
This capability is inherent to microRNAs (miRNAs), small
non-protein-coding RNAs known to play an important
role in development and disease by post-transcriptional
down-regulation of entire sets of target mRNAs [9-11].
Evidence supporting this hypothesis includes the facts
that miRNAs are up- and down-regulated in sensory
neurons in animal models of neuropathy, that certain
salient miRNAs are prominently expressed in nociceptors
and that pain is suppressed in transgenic mice in which
global miRNA expression in nociceptors was selectively
blocked [12-20]. This evidence, however, is not specific
to pain. For example, the types of nerve trauma used to
induce chronic pain also trigger changes in cell metabol-
ism and transport, nerve regeneration and apoptosis.
Our rat lines provide a strategy for spotlighting those
changes that are particular to pain. Specifically, we carried
out a genome-wide search for nerve injury-induced
changes in miRNA expression using both the pain-prone
(HA) and the pain-resistant (LA) line. Since the lines were
established by selection for neuropathic pain phenotype,
unrelated processes such as regeneration are not expected
to be line-specific. Following this strategy we asked whether
there are any miRNAs, or other potentially regulatory
small non-coding RNAs (sncRNAs), whose expression is
differentially regulated in association with pain phenotype.
Such genetic elements are likely to play a direct role in
neuropathic pain physiology.
Results
Unique sequences and miRNAs in the rat DRG
After editing, mapping and excluding rare sequences,
3340 unique “reads level” single-stranded RNA se-
quences 16–41 nt in length were found that were
expressed at RPM ≥10 (Reads Per Million) in at least 3 of
the 12 biological pools (3 pools each for HA_sham,
HA_SNL, LA_sham, LA_SNL). These included both
miRNA isoforms and other sncRNAs. The overall num-
ber of such reads per pool was ~12.3 × 106 with a re-
markably uniform across-pools average (RPM= 271 ± 4).Within pools, however, there was a broad scatter of abun-
dances with RPMs highly skewed towards the low end of
the range (Figure 1A). The most abundant unique sequence
had an RPM= 139,299 ± 43,970 across pools; for the least
abundant, RPM= 6 ± 6.
MiRBase-v19 recognizes a total of 723 mature miRNA
in the rat and many more in other species. Of these
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abundance in our DRGs. In addition, 11 novel miRNAs,
not previously reported in the rat (see below), passed
threshold yielding a total of 284 mature miRNAs in the
analysis. The overall abundance of mature miRNA reads
in each pool was ~3.6 × 106, about 30% of all reads. Total
reads per miRNA identifier name averaged 12,388 ± 2,337
across pools. As for unique sequence reads, RPM values
of the individual miRNAs filled a broad range across pools
(1 to 523,440), again highly skewed towards lower values
(Figure 1B). Additional file 1: Table S1 lists the 50 most
abundantly expressed miRNA species in the rat DRG. No
miRNAs were found to be expressed in one of the two
rat lines but not the other, and none appeared de novo,
or disappeared completely, after nerve injury. However,
relative abundances differed somewhat between HA and
LA rats at baseline, and abundances of some were signifi-
cantly altered by SNL nerve injury.Line differences in basal expression of short regulatory RNAs
Pain behavior was very different in HA and LA rats despite
their similar genetic background [3], with HA animals
achieving much higher autotomy scores than LA (Figure 2).
Consistent with their common ancestry we identified only
two miRNAs that were expressed at significantly different
baseline levels in HA_sham and LA_sham pools. These
were rno-miR-184 and rno-miR-6325, expressed 9.5-fold
and 2.8-fold higher in HA than LA rats, respectively. Both
occurred at low abundance (RPM= 22.7 and 16.1, respect-
ively in HA). For the remaining 282 miRNAs (99.3%) FDR


















Figure 2 Distribution of autotomy scores in HA and LA rats
from the same generations as the rats used for miRNA
sequencing. The scoring protocol is detailed in [2].unique sequences emerged as being differentially expressed
at baseline after FDR correction.
Effect of SNL nerve injury (SNL-reg)
Overall, about half of the 284 mature miRNAs in both
HA and LA rats were nominally up-regulated following
nerve injury (53.9% HA, 63.4% LA by subtraction method;
50.3% HA, 63.0% LA by log2 ratio). p-Values were signifi-
cant (p < 0.05) before correction for multiple testing in
n = 23 (HA) and n = 35 (LA). These are listed in Additional
file 1: Table S2. However, only one remained significant
after FDR correction for multiple testing (rno-miR-449c-
5p). This result differs markedly from full-length mRNAs
in which >10% of all expressed genes, >2,000, are signifi-
cantly up- or down-regulated by 3 days after nerve injury
[21-23]. The one exceptional miRNA was rare in both
lines (mean RPM= 12.2 (HA) and 11.4 (LA), sham pools)
and the degree of regulation did not differ between the
lines (fold-change = 3.85 (HA) and 3.19 (LA); p = 0.85).
Differential regulation of miRNAs following nerve injury
(diff-reg)
Like rno-miR-449c-5p, for most of the 284 mature miRNAs
the magnitude and direction of fold-change was similar
in HA and LA rats (Figure 3). However, 3 miRNAs were
regulated differentially (subtraction method, p < 0.05 after
FDR correction). Use of log2 SNL/sham ratio as a metric
of fold-change introduced a 4th and randomization (‘boot-
strap p-value’) brought the number to 5. The latter was
nearly significant by FDR t-test (p = 0.069). Of these 5
diff-reg miRNAs (Table 1) only one, rno-miR-30d-5p,
was abundantly expressed (RPM ~10,000, 15th ranked
in abundance overall, Additional file 1: Table S1). This
miRNA was down-regulated in HA and (slightly) up-regu-
lated in LA. The others had RPM ranging from ~30-100
and are hence unlikely to be of major functional signifi-
cance in the control of pain phenotype (see Discussion).
Pool consistency check and discretionary pool exclusion
Read counts were fairly consistent across pools. Consider-
ing all miRNAs in the 3 pools that made up each of the 4
experimental groups, the average coefficient of variation
(CV = SD/mean) was only 0.20. However, if a biological or
processing factor had increased variability in one of the
pools, important signals could be obscured. To check on
this we applied hierarchical cluster analysis to estimate pool
consistency under the premise that the 3 pools within each
experimental group ought to be more similar to one an-
other than to pools in the other groups. Results revealed
one HA_SNL pool, HA_SNL1, as a clear outlier (Figure 4A).
Analysis of RPM values across miRNAs in the 6 HA pools
also flagged HA_SNL1 as an outlier (Figure 4B). Finally,
this conclusion was consistent with the fact that variability



















Figure 3 SNL nerve injury induced roughly equal up- and
down-regulation (SNL-reg) of miRNAs in DRGs of HA and LA
rats (small red dots). Symbols to the right of, and above, the axes
indicate nominal upregulation. The few miRNAs that were differentially
regulated (diff-reg) are indicated by yellow triangles (rno-miR-30d-5p,
rno-miR-125b-5p and rno-miR-379-5p) or large blue dots. Regulation
was calculated using the subtraction method (SNL-sham/mean),
HA_SNL1 excluded.
Table 1 Mature miRNAs that underwent significant differenti
HA vs. LA rats






HA LA HA LA
subtraction method, all pools
rno-miR-30d-5p 9,187 11,047 8,140 11,168 −0.12
rno-miR-378b 51.6 47.1 58.6 33.7 0
rno-miR-322-3p 30.7 29.4 20.8 32.8 −0.3
added by log2 ratio method or randomization *, all pools
rno-miR-493-3p 79.8 66.3 87.9 91.0 0
rno-miR-1839-5p * 112.1 108.9 100.3 129.1 −0.1
added by HA_SNL1 pool exclusion
rno-miR-125b-5p 3,758 2,537 2,718 2,398 −0.32
rno-miR-379-5p 201.9 187.5 188.6 231.6 −0.06
rno-miR-369-3p 12.0 13.6 16.9 15.8 0
rno-let-7f-2-3p 11.7 8.1 10.4 12.8 −0.1
rno-miR-340-3p 8.9 11.5 12.6 9.3 0
rno-miR-6331 15.0 10.5 11.8 13.2 −0.2
Relatively abundant transcripts are in bold font.
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LA_sham = 0.20, LA_SNL = 0.16). These observations jus-
tify excluding the outlier pool and basing results on only 11
of the 12 pools. However, to avoid potential appearances of
bias we chose to present results obtained by computing
SNL-reg and diff-reg both with and without pool exclusion.
None of the mature miRNAs (n = 284) or unique se-
quences (n = 3340) were eliminated because of the exclu-
sion. However, reduced variability in the HA_SNL group
following exclusion of the outlier pool yielded 6 additional
significant differentially regulated miRs (Table 1). One,
rno-miR-125b-5p, was abundantly expressed (RPM ~3000,
ranked 30th overall, Additional file 1: Table S1); it was
down-regulated in HA and marginally so also in LA.
An additional one was expressed at modest abundance
(rno-miR-379-5p, RPM~ 200) and the remaining 4 were
rare (RPM < 15). Considering the two computations to-
gether, 11 miRNAs were differentially regulated at cri-
terion significance after correction for multiple testing,
3 at abundant or moderate levels (Table 1, Figure 5).
Additional file 1: Table S3 lists the top miRNAs ranked
by the statistical significance of diff-reg. Additional file 1:
Table S4 lists the top miRNAs ranked by the magnitude of
diff-reg.
PCR verification
Regulation of the 3 abundant diff-reg miRNAs was verified
using qRT-PCR. All were significantly downregulated in
HA rats and 2 were significantly upregulated in LA rats.
For all 3, significant differential regulation was confirmedal up- or down-regulation following SNL nerve injury in
eg subtraction method
sham fold-change)
diff-reg qFDR chr. #
HA LA HA-LA HA-LA
1 (−1.129) 0.011 (1.011) −0.132 (0.297) <0.001 7
.125 (1.136) −0.331 (−1.398) 0.457 (0.533) <0.001 5
84 (−1.476) 0.109 (1.116) −0.494 (0.592) <0.001 X
.138 (1.102) 0.455 (1.373) 0.317 (0.271) <0.001 6
10 (−1.118) 0.168 (1.185) −0.278 (.303) <0.05 1
1 (−1.383) −0.056 (−1.058) −0.265 (0.325) 0.002 8
8 (−1.071) 0.210 1.235 −0.278 (0.306) 0.04 6
.337 (1.408) 0.148 (1.162) 0.189 (0.246) 0.03 6
19 (−1.125) 0.448 (1.580) −0.567 (0.705) 0.03 X
.346 (1.416) −0.215 (−1.237) 0.561 (0.653) 0.03 10
41 (−1.271) 0.226 (1.257) −0.467 (0.528) 0.05 6
BA
Figure 4 Outlier status of the HA_SNL1 pool. A) Hierarchical
dendrogram based on pool similarity and B) HEAT maps [24] both
illustrate the outlier status of the HA_SNL1 pool. HEAT map columns
use color to represent the 284 miRNAs in the 3 HA_sham pools and
the 3 HA_SNL pools. The miRNAs are arranged in decreasing order
of average RPM in the HA_sham group. Color (scale above) represents
relative RPM where 0 (orange) is the mean RPM of the 6 pools and +2
(red) and −2 (yellow) represent ±2 standard deviations [24].
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regulation consistent with observations using miRNA-seq.
Up- and down-regulation of unique short RNA sequences
Figure 7 shows a histogram of read lengths of all short
RNA sequences in the 6 HA pools (results for LA
were very similar). Note that the most common reads
were ~22 nt in length, the miRNAs. However, there were
two smaller peaks at 17–18 nt and 33 nt. Interestingly, in
this analysis too, the HA_SNL1 pool emerged as an out-
lier, with an exceptionally high proportion of miRNAs and
a low proportion of other sncRNAs. sncRNAs that are not
miRNAs can regulate gene expression and the same may
be true of individual miRNA sequences (isomiRs) among
the many similar but non-identical ones that map to a par-
ticular canonical miRNA identifier.
To locate unique sequences that were regulated by SNL
nerve injury we ran the SNL-reg and diff-reg computations
using as input matricies the 3340 reads-level sequences
detected at criterion abundance in the experimental pools.
No individual unique sequences were significantly regulated
by SNL nerve injury after FDR correction (in all pools, or
after HA_SNL1 exclusion). However, 7 showed significant
differential regulation (all pools analysis). It is unlikely that
these hits were sequencing artifacts as each occurred in
all 12 pools, with RPM ≥10 in most. The 7 included one
isomiR (of rno-miR-101a-3p, RPM~ 10), two rRNA frag-
ments, two tRNA fragments and two unidentified. Analysis
after excluding the HA_SNL1 pool yielded an additional
33 diff-reg sequences. Among these were one isomiR of
rno-miR-130a-3p and one of rno-miR-125b-5p (a miRNA
already identified as differentially regulated, Table 1).
Interestingly, the canonical miRNAs of all three diff-reg
rat isomiRs were abundantly expressed (RPMs ~3,500, 450,
3,150 respectively). The differentially regulated isomiR of
rno-miR-125b-5p (RPM ~35) differed from the consensus
sequence of its canonical miRNA only by deletion of the
nucleotides uga from the 3’ end [ucccugagacccuaacuug
uga]. It is noteworthy that individual isoforms of a given
miRNA may be regulated to different degrees by nerve
injury than others, and than the miRNA’s consensus se-
quence. As such, some might be more potent regulators
of gene expression than the other isomiRs that comprise
the miRNA.
The remaining 31 unique sequences included one isomiR
of a miRNA previously recognized in the Tasmanian devil
but not in the rat (sha-miR-5105), 9 rRNA fragments, 13
tRNA fragments and 8 unidentified sequences. All but 3 of
the 33 sequences (including the isomiRs) had RPM< 50.
The exceptions were one rRNA (RPM~ 800) and two
tRNA fragments (RPM~ 700 and 100; Table 2). We further
explored their alignment patterns and found that all 3 RNA
elements are mapped by >2000 unique reads. These reads
were not homogenously spread over the sequences, but
Figure 5 Only a small fraction of miRNAs were regulated differentially by SNL nerve injury in HA compared to LA rats. In this “volcano
plot” each dot represents one of the 284 miRNAs detected in the DRGs studied, with the degree of differential regulation (diff-reg, LA-HA)
plotted against the statistical significance of the diff-reg (FDR corrected q-values, given as -log10). LA-HA was calculated as the difference
between the mean log2 ratios of LA_SNL/LA_sham and HA_SNLl/HA_sham (average of pool values). Data used for the plot excluded outlier








































Figure 6 Differential regulation of miRs 125b-5p, 30d-5p and
379-5p was confirmed using qRT-PCR. Columns represent up- and
down-regulation of miRNA expression in SNL operated HA and LA rats
as a percent of sham control values. * p≤ 0.05 vs. sham; † p≤ 0.05
comparing regulation in HA vs. LA (diff-reg), one-way ANOVA followed
by Turkey post-hoc test.
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that the fragments were products of regulated processing
rather than random RNA degradation.
Novel rat miRNAs
We detected 13 pre-miRNAs novel for the rat. For 5 of
the pre-miRNAs we detected mature miRNAs from both
3’ and 5’ arms, for a total of 18 novel mature miRNAs
(Additional file 1: Table S5). Among the 18, 14 had ho-
mologs in other species (most in the mouse) and 4 are
reported here for the first time. We have named most
of the 14 rat homologs using the mouse identifier number
prefixed by rnoH (rnoH-miR). One of the 14 was previ-
ously reported in a variety of mammalian species (several
primates, cow, dog and horse), but not in rodents. The
best match was the horse homolog eca-miR-1271, and
hence our designation rnoH-miR-1271. One of the 18
was recognized in the newly released miRBase-v20
(rno-miR-155-5p). For one rat pre-miRNA both mature
miRNAs were expressed and their sequences matched
those in the mouse perfectly (mmu-miR-486; the complete



























Figure 7 Histogram showing that the small non-coding RNAs in the rat DRG fall into three categories by size: 17–18 nt, 21–23 nt
(miRNAs) and 32–34 nt. The HA_SNL1 pool (black columns) stands out as having relatively more miRNAs than the other pools.
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ranked 7th in Additional file 1: Table S1 and S5). The 4
sequences (2 pre-miRNAs) with no known homologs in
miRBase-v19 (or -v20) were designated rno-miR-X1 and
X2 in Additional file 1: Table S5. All occurred at very low
abundance, but were present in many pools and hence are
unlikely to represent read errors. Four of the 18 novel
miRNAs were among the 50 most highly expressed
miRNAs in the rat DRG (mmu-miR-486-5p, rnoH-miR-
148a-3p, rnoH-let-7 g and rnoH-miR-676-3p, set in italics
in Additional file 1: Table S1). None of the novel miRNAs
showed significant SNL-reg or diff reg.
Bioinformatic evaluation of the differentially regulated
miRNAs
Validated targets
We searched for validated target mRNAs for the 11 sig-
nificantly diff-reg mature miRNAs and for the canonicalTable 2 Unique sequences of miRNA isoforms (isomiRs) and ot
(qFDR < 0.05) differential up- or down-regulation following SNL
Small RNA type and sequence Mean RPM Mean
(canonical miRNA or RNA type) (sham pools) (SNL
HA LA HA
unique-sequence miRNA isoform (isomiR), all pools, and those added b
UAUAGUACUGUGAUAACUGACU (rno-miR-101a-3p) 11.7 9.3 9.9
CAGUGCAAUGUUAAAAGGGC (rno-miR-130a-3p) * 38.0 41.9 48.2
UCCCUGAGACCCUAACUUG (rno-miR-125b-5p) * 47.8 30.4 35.5
UGGACGGUGUGAGGCC (sha-miR- 5105) * 11.0 15.6 13.5
unique-sequence sncRNAs with RPM ≥100, after HA_SNL1 pool exclusio
AGCCGCCUGGAUACCGCAGCUAGGAAUAA (rRNA) 1843.3 616.5 548.0
GCAUUAGUGGUUCAGUGG (tRNA) 621.1 719.9 771.1
UCAUUGGUGGUUCAGUGG (tRNA) 88.6 111.5 114.1miRNAs for which one or more unique sequence iso-
miRs was differentially regulated (although not the ca-
nonical miRNA itself; Tables 1 and 2). In addition, we
queried the two miRNAs that were differentially expressed
at baseline (HA_sham vs. LA_sham). Results are sum-
marized in Table 3. A total of 53 validated target genes
were identified for the 11 miRNAs. Most had no known
validated targets, but the two most abundant ones (rno-
miR-30d and rno-miR-125b-5p) had 50 amongst them.
Three targets stood out as known players in pain
physiology. These were Tnf, Bdnf and Stat3, genes that
code for the cytokine TNF (tumor necrosis factor
[25-27], the growth factor BDNF (brain-derived neuro-
trophic factor [28-30]; and the transcription factor
STAT3 (signal transducer and activator of transcription 3
[31,32]). mRNA for TAC1 (tachykinin precursor 1) is a
target of the canonical miRNA of one of the diff-reg
isomiRs (Table 3).her sncRNAs (with RPM ≥100) that underwent significant
nerve injury in HA vs. LA rats
RPM SNL-reg diff-reg
pools) subtraction method (SNL/sham fold-change)
LA HA LA HA-LA
y HA_SNL1 pool exclusion *
11.3 −0.167 (−1.182) 0.194 (1.215) −0.361 (0.397)
45.0 0.237 (1.268) 0.071 (1.074) 0.166 (0.194)
33.1 −0.295 (−1.346) 0.085 (1.089) −0.380 (0.435)
11.9 0.204 (1.227) −0.269 (−1.311) 0.473 (0.537)
n
666.0 −1.846 (−3.363) 0.078 (1.080) −1.924 (2.443)
713.5 0.215 (1.242) −0.009 (−1.009) 0.224 (0.251)
103.4 0.252 (1.288) −0.075 (−1.078) 0.327 (0.366)
Table 3 Number of validated mRNA targets of miRNAs that were differentially up- or down-regulated by SNL nerve injury
miRNA identifier RPM mean








rno-miR-378b 49.4 0.457 0
rno-miR-322-3p 30.1 0.494 2 -
rno-miR-30d-5p 10,117 0.132 5 Bdnf
rno-miR-493-3p 73.1 0.316 0
rno-miR-1839-5p 110.9 0,278 0
rno-miR-125b-5p 3147.6 0.265 45 Tnf, Stat3
rno-miR-369-3p 12.8 0.189 0
rno-let-7f-2-3p 9.9 0.567 0
rno-miR-340-3p 10.2 0.561 1 -
rno-miR-6331 12.8 0.467 0
rno-miR-379-5p 194.7 0.278 0
Canonical miRNA of unique sequence isomiR (diff-reg of isomiR)
rno-miR-101a-3p 1735.9 0.079 28 -
rno-miR-130a-3p 470.8 0.160 16 Tac1
Differential expression at baseline (HA_sham vs. LA_sham) all pools
rno-miR-184 25.2 0.550 4 -
rno-miR-6325 16.4 0.114 0
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For the 3 diff-reg miRNAs of high or moderate abundance
we also explored predicted, but not (yet) verified, mRNA
targets. Since hundreds were found for each, we carried
out a systems level analysis to define which Gene Ontol-
ogy (GO) molecular function terms were enriched that
characterize the collection of target genes in comparison
with the genome in general. The most notable observa-
tions were enhanced ion, protein and nucleic acid binding,
and hence possibly regulation, among the protein targets
of rno-miR-30d-5p and rno-miR-125b-5p, and enriched
ion channel activity, including Na+ channel activity, in
rno-miR-125b-5p (Figure 8).
Discussion
We applied a distinctive genome-wide search strategy to
rat selection-lines that have similar genetic background,
but contrasting pain phenotype. The aim was to discover
miRNAs related to neuropathic pain while avoiding
processes such as cell metabolism, regeneration and apop-
tosis that are also triggered by nerve injury but that do not
differ between the lines [33]. Overall we encountered only
three miRNAs that were present in significant copy number
and were regulated differentially by nerve injury in HA vs.
LA rats. These were rno-miR-30d-5p and rno-miR-125b-
5p which were expressed abundantly and rno-miR-379-5p
which was expressed at modest copy number. Eight
additional diff-reg miRNAs were found. But since theywere rare, it is unlikely a priori that they are functionally
important. This determination rests on the observation
that most miRNAs for which a significant biological role
has already been established are abundantly expressed.
Furthermore, experimental use of decoy libraries has shown
that in general, miRNAs expressed at 100 RPM or less are
unlikely (<2%) to detectably suppress the expression of any
target mRNA [34], let alone to have a prominent behavioral
effect. Indeed, the 8 low-abundance miRNAs might not
have been differentially regulated at all. Some or all of these
hits probably met the significance criterion by chance
(type 1 error). Since the ~3.5 × 106 miRNA reads in each
pool represent only ~0.001% of the actual number of
miRNA molecules loaded into the sequencer, stochastic
effects can generate false positives, especially for low-
abundance sequences [35]. Consider that a random (or
read-error) difference of only a few reads on a baseline
RPM= 10 translates to a much larger fold-change than
the same error on a baseline of RPM= 1000.
Genome-wide scans typically yield large numbers of
hits requiring prioritization based on factors such as
magnitude of fold-change ratio or occurrence in several
different pain models [36]. This is risky and possibly even
counterproductive as it might highlight processes such as
regeneration and metabolism that are generic to nerve in-
jury but not necessarily to pain. The approach is also likely
to obscure transcripts related to particular pain conditions
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Figure 8 Pie charts show the Gene Ontology (GO) molecular function terms that are enriched compared to the overall genome, among
the mRNA targets predicted by the TargetScan algorithm for miR-125b-5p (n = 451) and miR-30d-5p (n = 1094).
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cast a broad net which included diff-reg miRNAs obtained
with and without exclusion of outlier pool HA_SNL1, two
different methods of calculating regulation and canonical
miRNAs of unique sequence diff-reg isomiRs. Nonethe-
less, a very small number of diff-reg miRNAs were found
and these turned out to be regulators of established major
pro-nociceptive molecules. This affirms the intrinsic power
of the strategy to prioritize pain-relevant transcripts [33].
We believe that the key factor was comparison of animals
with very similar pedigree but strongly contrasting pain
phenotype. Standard commercial strains show robust dif-
ferences in constitutive miRNA expression [37] while in
HA/LA rats we found only two miRNAs with a consti-
tutive expression difference at baseline (sham-operated).
Even these are questionable given their very low abundance
(RPM~ 10). Another factor was harvesting DRGs only
3 days postoperatively. Up- or down-regulation of miRNAs
after nerve injury is progressively more robust over the first
weeks postoperative. By 2–4 weeks a much larger fraction
of expressed miRNAs are regulated [15,38,39]. Since dif-
ferential pain phenotype in our rats is robust by 3 dpo [3]
sequences that begin to show regulation only later areunlikely to be causative. We conclude that rno-miR-30d-
5p, rno-miR-125b-5p, and perhaps rno-miR-379-5p are
fundamental to the contrasting neuropathic pain pheno-
type in HA vs. LA rats. Since the contrast includes
spontaneous pain as well as tactile allodynia [3] these
miRNAs may be important players in neuropathic pain
in general. Regulation of these miRNAs in the DRG fol-
lowing nerve injury has been noted previously (e.g.
[38]), but they have not been specifically implicated as
key factors in neuropathic pain.
Downstream targets of the differentially regulated miRNAs
The 8 rare diff-reg miRNAs, and the modestly expressed
rno-miR-379-5p, had only 3 verified mRNA targets among
them, none that hinted at a role in pain physiology. The
two abundantly expressed diff-reg miRNAs had more,
including 3 that code for well-known pro-nociceptive
compounds, TNF, BDNF and STAT3 (Table 3). This rep-
resents notable enrichment of pain-related molecules. Since
both miRNAs were more down-regulated in pain prone
HA rats than in LA rats, and miRNAs suppress the ex-
pression of their mRNA targets, this regulation is expected
to increase target gene product levels in HA vs. LA.
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by DRG neurons and glia in inflammatory and neuro-
pathic pain models and are strongly pro-nociceptive
[25,26,28,29,40,41].
Interestingly, specific knockout of BDNF expression in
small diameter neurons was found to have little effect
on pain behavior 3 days postoperatively, indicating that
BDNF in nociceptors does not play a significant role in
neuropathic pain phenotype [42]. However, BDNF expres-
sion in larger DRG neurons (Aβ-afferents) and glia is not
eliminated in these knockout mice. Indeed, as noted,
BDNF expression is markedly increased in large diameter
afferents following axotomy [28,29]. This reiterates the
special role of activity in Aβ afferents as drivers of neuro-
pathic pain [43]. In addition, it suggests that regulation by
miRNAs might be a particularly important factor in the
phenotypic switching of Aβ touch-signaling neurons, a
change that contributes importantly to their seemingly
paradoxical involvement in pain perception in the event of
neuropathy [5,44].
STAT3, a transcription factor in the JAK-STAT pathway,
is activated in sensory neurons and glia following noxious
stimulation and nerve injury and is also associated with
potentiation of pain [31,45]. Thus, the selective downregu-
lation of all 3 diff-reg miRNAs likely contributes to the
prominent afferent hyperexcitabilty of HA rats [4] and
hence to their marked neuropathic pain phenotype.
As noted above, Tnf, Bdnf and Stat3 have already been
verified experimentally as targets of rno-miR-30d-5p and
rno-miR-125b-5p, and functional assays involving primary
afferents have already established all three as major players
in pain physiology. Additional corroboration has therefore
not been undertaken here, although the issue of whether
miRNA-regulated expression is selective to particular types
of DRG neurons, but not others, deserves follow-up.
We conclude that neuropathy-induced regulation of these
diff-reg miRNAs contributes to the control of individual
variability in neuropathic pain phenotype. Further research
is required to determine whether some of the other known
or predicted gene targets of rno-miR-30d-5p and rno-
miR-125b-5p might also contribute. In this regard it is
noteworthy these targets in part relate to inflammatory
processes and not strictly to processes of neuropathic
(electrical) excitability. Indeed, it is clear that inflamma-
tory mediators exacerbate ectopia in afferent neurons,
blurring the line between neuropathic and inflammatory
pain [1,15,26,29,41].
A key strength of whole-genome search strategies is
their ability to reveal elements not previously associated
with pain processing. TNF, BDNF and STAT3 were
highlighted because of prior knowledge of their prominent
role in pain. However, in vivo all of the genes targeted by
our 3 miRNA hits are potentially down-regulated. We
must imagine that the contrasting pain phenotype of HAvs. LA rats is orchestrated by differential regulation of the
entire constellation of their target genes. The list of targets
already validated, and those yet to be validated, constitutes
a useful pool of pain-related genes. In this regard it should
be noted that since RNA was extracted from whole DRGs,
non-neural cells in the ganglia might also have contrib-
uted to the yield of diff-reg miRNAs.
Unique sequence miRNA isoforms (isomiRs) and
other sncRNAs
Small sequence differences among isomiRs can affect
binding affinity to mRNA targets [35,46]. Thus, a par-
ticularly potent individual isomiR, or a small subset,
could be responsible for a large proportion of the func-
tional effect of the canonical miRNA. Indeed, in three
instances the fold-change of one isoform reached stat-
istical significance even though that of its canonical
miRNA did not (Table 2). In each case the isomiR con-
tributed only a small fraction of the overall RPM of the
miRNA. The canonical miRNA of two of these, rno-101a-
3p and rno-miR-130a-3p, had a variety of validated mRNA
targets (n = 44, Table 3). Differentially regulated isomiRs
merit further exploration. Likewise, diff-reg sncRNAs that
are not miRNAs might be significant mediators of pain
variability. Our reads level analysis identified a number
of candidates. Many of these were parsed as tRNAs or
rRNAs. Three of them were relatively abundant (Table 2)
and showed signs of being processed rather reflecting
random RNA degradation. These sequences also merit
further study.
The contribution of miRNA regulation to neuropathic pain
Nerve injury is consistent in causing negative symptoms,
hypesthesia and numbness, in the corresponding body
part. Positive symptoms, paresthesias and pain, are much
more variable indicating that the nerve lesion is not
causative in itself. Among major limb amputees, for ex-
ample, <25% report persistent severe phantom pain [47]
while <0.01% of adults have trigeminal neuralgia among
the ~17% who have the (putative) causative nerve lesion
[48]. Genetic polymorphism is believed to be a key co-
factor determining whether or not nerve injury will lead
to neuronal hyperexcitability and neuropathic pain.
However, the widely used approach of simply identifying
genes regulated by nerve injury is an inefficient route
for discovering the polymorphisms and pathways that
play a special role in pain processing. The problem is that
thousands of mRNAs are regulated following nerve injury
[21-23,33]. It is very difficult to delineate which contribute
to enhanced pain sensibility and which are related to other
processes triggered by nerve injury. A systematic means is
required to solve this problem. The strategy used here,
examining differential effects of nerve injury in animals
that are genetically similar but different in pain phenotype,
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regulated miRNAs and other sncRNAs were identified,
and even fewer remained candidates after (tentative)
exclusion on the basis of low copy number. Prioritizing
candidate genetic elements using this strategy is likely
to have general applicability to problems in which there is




Observations were made on DRG tissue taken from adult
HA and LA rats of both sexes raised in our Institute ani-
mal facility under SPF (specific pathogen free) conditions.
HA and LA rats were derived from outbred Wistar-based
Sabra strain rats by genetic selection as described by
Devor and Raber [2]. They show contrasting pain pheno-
type in both the neuroma and the spinal nerve ligation
(SNL) models of neuropathic pain [1,3,49]. The animals
used for this study were from the 63rd (HA S63) and the
61st (LA S61) generations of selection and had been in-
bred for the previous 12 generations. The animals were
contemporaneous despite the different generational desig-
nations. This is due to somewhat quicker selection in the
HA line. Before and after surgery animals were housed in
plastic cages at an ambient temperature of 22 ± 1°C and a
12 hr diurnal light cycle with lights on at 6:00. Pelleted
food (Teklad, #2018FC + F) and water were provided ad
libitum. Cages were cleaned twice weekly. Experiments
were approved by the Institutional Animal Care and
Use Committee (IACUC) of the Hebrew University of
Jerusalem, and followed IASP (International Association
for the Study of Pain) guidelines for the humane use of
laboratory animals.
Four equally sized experimental groups were formed
from HA and LA rats that underwent either SNL or
sham surgery. They are designated HA_SNL, HA_sham,
LA_SNL, and LA_sham. Rats were deeply anesthetized
with 4% chloral hydrate (400 mg/100 g body weight, i.p.).
Using antiseptic precautions the lower lumbar spine was
exposed and the L6 transverse process was removed, bilat-
erally in most animals, to reveal the left L4 and L5 spinal
nerves. These were transected 4–5 mm distal to the DRG
(no ligature). A carbon mark was placed near the cut
nerve ends to facilitate postmortem identification. In
sham-operated rats, the spinal nerves were exposed, but
not touched. The incision was then closed in layers using
discontinuous silk sutures in muscle and Michel skin clips.
Antibiotic powder was applied to the incision and a single
prophylactic injection of ampicillin was given (50 ku/kg
i.m.; Sandoz, Kundl, Austria). The accuracy and complete-
ness of the intended surgery was confirmed visually at
the time of DRG harvesting. This included postmortem
dissection of the lumbosacral plexus in a sample of rats.Tissue collection, RNA extraction and sequencing
Three days after SNL or sham surgery the animals were
again anesthetized with chloral hydrate and the L4 and
L5 DRGs were removed and trimmed of fat and connect-
ive tissue. The spinal nerve and roots were then shortened
to about 1 mm, and the DRGs were rinsed in sterile saline,
immersed in ice cold RNA stabilization reagent (RNAlater,
150 μl, Qiagen GmbH, Hilden, Germany, product # 76101)
and rapidly frozen. The rats were then killed by anesthetic
overdose and cervical dislocation. Only ~2 min elapsed
between DRG removal and freezing. L4 and L5 DRGs
from the operated side of each rat were collected in individ-
ual labeled Eppendorf vials and stored at −70°C pending
RNA extraction. Each vial contained one DRG. To ensure a
high enough starting RNA concentration we formed bio-
logical samples by pooling 12 DRGs. These were provided
by 3 or 4 rats from each of the four experimental groups,
balanced for sex but otherwise chosen at random. Thus,
for each group there were three biological replicates
(pools) for a total of 12 pools (and 144 DRGs) altogether.
The pools were designated HA_SNL1, 2 and 3, LA_sham1,
2, 3, and so forth.
Total RNA was isolated using the mirVana™ miRNA Iso-
lation Kit (Applied Biosystems, Carlsbad, CA, AM #1561)
following manufacturer instructions. The total miRNA frac-
tion was dissolved in nuclease-free water and purification
steps were performed using Qiagen kit #79254 following
manufacturer instructions. RNA concentration was deter-
mined using the NanoDrop spectrophotometer (NanoDrop
Technologies, Wilmington, DE) and the quality of the total
RNA was checked by gel analysis using the total RNA
Nanochip assay on an Agilent 2100 Bioanalyzer (Agilent
Technologies GmbH, Waldbronn, Germany). 250 ng of
RNA obtained from each pool of 12 DRGs was used as
starting material for miRNA deep-sequencing analysis.
Sequencing was carried out at GATC Biotech (Constanz,
Germany) using the Illumina Hiseq 2000 sequencer, follow-
ing established in-house protocols [GATC Biotech: DNA
Sequencing and Bioinformatics (http://www.gatc-biotech.
com/en/index.html).
For each of the 12 pools GATC Biotech provided raw
Fastq files that listed the number of reads of each unique
RNA sequence with length ranging up to 41 nucleotides
(≤41 nt). After appropriate editing and mapping (below)
these files were used to identify miRNAs present in the rat
DRGs, to determine effects of SNL nerve injury (up- and
down-“regulation” (SNL-reg)) and to identify miRNAs for
which nerve injury-induced regulation differs between the
two rat lines (“differential regulation” (diff-reg)).
Sample validation by PCR
RNA-seq data were validated with quantitative real-time
polymerase chain reactions (qRT-PCR) in a sample of
7 miRNAs including the 3 most abundant ones with
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specific first strand cDNA 20 ng of total RNA was reverse
transcribed with miRNA-specific RT primers using the
TaqMan® MicroRNA Reverse Transcription Kit (Ap-
plied Biosystems, #4366597) following the manufacturer’s
instructions. Prepared cDNA template was PCR ampli-
fied in each reaction using corresponding miRNA-
specific primers and TaqMan® Universal Master Mix II -
no UNG (Applied Biosystems, #4440040, manufacturer’s
instructions) on a LightCycler® 480 Real-Time PCR System
(Roche Diagnostics GmbH, Germany). The target miRNAs
(and corresponding assay numbers) were: rno-miR-23a
(000399), rno-miR-26b (000407), rno-miR-30-5p (000420),
rno-miR-101b (002531), rno-miR-125b-5p (000449),
rno-miR-379 (001138) and rno-miR-431 (001979). Ex-
pression levels were normalized to that of U87, a small
nucleolar RNA (assay number: 001712).
Editing and mapping
Editing
Our starting point was the Fastq file for each of the 12
pools. Using miRanalyzer (standalone version [50]), the
raw reads in each pool were sorted into unique sequences
and their corresponding abundances (read counts). These
were edited to construct final expression matrices suitable
for calculating nerve injury-induced regulation (SNL-reg)
and differential regulation (diff-reg). First, adapter sequences
were trimmed from the raw reads by forcing the detection
of at least 10 nt of the adapter, allowing one mismatch.
Reads for which no adapter sequence was detected, and
reads shorter than 16 nt, were removed from the analysis
retaining only sequences 16–41 nt in length. Note that the
size filters retained RNAs 16–20 nt and 24–41 nt in
length, forms too small and large to be miRNAs (Figure 7).
The rationale was that some sncRNAs in these size ranges
might nonetheless play a regulatory role analogous to
miRNAs [15,51,52]. The outcome of editing was an ex-
pression matrix listing the total number of reads of each
unique small RNA sequence (“read-level counts”).
Mapping
The edited reads were then assigned a type (annotated) by
mapping to several sequence libraries, in a fixed order.
Our mapping pipeline took into account different ways in
which RNA molecules can be post-transcriptionally modi-
fied. For example, in addition to RNA editing it has been
shown recently that RNA molecules may be modified by
adding uracils (uridylation) and adenines (adenylation)
to the 3’ end (NTA, non-templated addition, [53]). Since
these additions are not present in the library consensus
sequences, NTAs can produce mismatches in the alignment
between the read sequence and the miRNA consensus
sequence. Strongly modified reads might not be mapped
at all. To correct for this we used Bowtie seed alignment[54]. Briefly, we aligned only the first 20 nt of each read
(the “seed”) to the sequence libraries, ignoring all mis-
matches beyond the 20th nt. In this way, NTAs do not
cause mismatches and the corresponding sequences are
mapped. Finally, to accommodate for sequencing errors
and rare RNA editing events we allowed one mismatch
when mapping to known miRNAs, and two mismatches
when searching for putatively homologous miRNAs.
Note that miRNAs with unique miR identifier names in
the miRBase library [55-58] usually map more than one
unique read sequence. To refer to the set of unique se-
quence isoforms that map to a particular miR identifier
(sometimes dozens) we use the term “isomiRs”. The iso-
miRs of a particular miRNA are thought to derive from a
unique DNA level miRNA gene, but are non-identical due
to post-transcriptional processing which deletes or adds
one or two nt’s [35,46]. Mapping used the following seven
libraries, in this order: (i) known rat (Rattus norvegicus)
miRNAs (rno-miRs, miRBase-v19 [58], (ii) all known
miRNAs (species-miR, miRBase-v19), (iii) REfSeq genes
[59] (iv) Rfam (v. 11) [60] (v) t-RNAs [61] (vi) RepBase
repetitive DNA [62] and (vii) piwi-RNAs, obtained using
the NCBI nucleotide database using “piRNA, piR, rattus
norvegicus” as search terms. Our main analysis used the
first two libraries. The others were used for annotating
reads-level results. Once a read was successfully aligned
to a named consensus sequence in a library, the now
identified read sequence was removed from the input to
the next library in the order. This prevented mapped se-
quences from being erroneously counted twice. Sequences
that ran through all libraries without being assigned a
miRNA identifier name or being otherwise annotated
were left unnamed, but were nonetheless included in
the final reads-level matrix used for calculating SNL-
regulation and differential regulation.
Following mapping, we converted the read count of each
short RNA element into “reads per million” (RPM). This
was done independently for each of the 12 pools in two
alternative ways: 1) In “within-library normalization” the
number of reads assigned to a unique identifier name in
a given library (e.g. rno-miR-143-3p in library (i)) was
normalized to the total number of reads identified by all
identifiers in that library. 2) Alternatively, in “reads-level
normalization” the number of reads of each unique se-
quence in a pool was normalized to the total number of
reads of all sequences in that pool. Finally, we excluded
low abundance miRNAs by deleting all RNA elements
(miRNAs, other sncRNAs and un-named sequences) for
which RPM was not ≥10 in at least 3 of the 12 pools.
Test for pool consistency
The 12 DRGs in each pool originated from 3–4 rats and
had been individually hand dissected and trimmed. To
evaluate the possibility of an abnormality in one or more
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assumption that pools compared within each experimental
group should be more self-similar than pools compared
across groups. This was done using a hierarchical clustering
algorithm (average linkage) implemented with Cluster 3.0
[63]. The distance metric used was the pairwise correlation
coefficient between RPM profiles of two samples.
Calculation of miRNA regulation and differential regulation
We calculated for each of the 12 pools SNL-reg, the degree
to which the expression of individual named miRNAs and
other small RNA sequences was up- or down-regulated by
SNL nerve injury. Then we identified elements for which
nerve injury-induced regulation differed significantly, in
degree and/or direction, in HA vs. LA rats (diff-reg). These
calculations were based on RPM values of the RNA
element, and were done separately on two different data
matrixes: a) Mature miRNAs and b) All unique read se-
quences, including individual miRNA isoforms (isomiRs)
and other sncRNAs.
SNL injury-induced regulation (SNL-reg)
Because there is no unique measure of regulation we cal-
culated SNL-reg in two ways. The first was (SNL-sham)/
(mean of SNL + sham). Thus, for each mature miRNA the
mean RPM of the 3 HA_SNL pools was subtracted from
the mean RPM of the 3 HA sham pools and the result
was divided by the average of all 6 HA pools. This was
repeated for LA. Nerve injury-induced up-regulation yields
positive values, down-regulation negative values and no
change zero. We also calculated fold-change ratio. Since
SNL/sham yields values >1 for up-regulation, but positive
fractional values (rather than negative values) for down-
regulation, log2 of SNL/sham was used for statistical com-
putations. The null hypothesis of no difference between
SNL and sham was tested using 1-tailed t-tests. The FDR
limit [64] was also computed (for α = 0.05) and used to
correct for multiple testing as explained below. For the
much larger reads-level matrices of unique sequences
SNL-reg was calculated using the DESeq routine in the
R statistical software package [65].
Differential regulation (diff-reg)
Diff-reg for mature miRNAs was evaluated statistically as
follows: For each element in each of the 3 HA_SNL
pools we calculated SNL-reg with respect to each of
the HA_sham1, HA_sham2 and HA_sham3 pools.
Thus, we calculated (HA_SNL1- HA_sham1)/mean,
(HA_SNL1- HA_sham2)/mean, (HA_SNL1- HA_sham3)/
mean, (HA_SNL2- HA_sham1)/mean and so forth. This
was repeated for LA. The result was 9 estimates of SNL-
reg for HA and 9 estimates for LA, each with a corre-
sponding mean ± SD (standard deviation). The same was
done using log2 ratio fold-change. For unique sequencesonly log2 ratio was used. To obtain diff-reg, we compared
mean SNL-reg from the HA and LA lines using 2-tailed
t-tests followed by computation of the corresponding
FDR. For extra confidence we also implemented an algo-
rithm that compared RPM means in 10,000,000 random
runs for each miRNA [66]. This approach is free of as-
sumptions concerning the particular distribution of the
underlying RPM values.
Statistical correction for multiple testing
For both SNL-reg and diff-reg the null hypothesis of no
regulation was rejected for all RNA elements for which
uncorrected p ≤ FDR limit [64]. DESeq also corrects for
multiple testing, using the Bonferroni method (padj). Cor-
rected p ≤ 0.05 was considered significant. Mean values
are given throughout ± SD.
Bioinformatic data analysis
Prediction of novel miRNAs
We first pooled all 12 samples together. After adapter
trimming and collapsing the redundant sequences into
unique read counts, we removed all sequences with fewer
than 5 reads. The remaining reads were then used to
predict novel miRNAs. Using miRanalyzer [50], we first
clustered reads that mapped to the same position on the
chromosome, allowing a window of 2 nt around the
start position of the most frequent read. Several putative
pre-miRNAs were then extracted from the genome se-
quence around each read cluster. These sequences were
analyzed for “candidates” by RNAfold retrieving of those
with the lowest energy that show a hairpin secondary
structure. Finally, a machine learning algorithm was
applied to each candidate yielding the final novel sequence
predictions. After obtaining the predicted miRNAs we
applied further thresholding, as follows, in order to reduce
the number of false positive predictions: i) minimum read
count ≥ 10 for the most frequent read, ii) length of the
most frequent read between 20 nt and 23 nt, and iii) fluc-
tuation around the 5’ start of the mature miRNA within
2 nt. Last, for rat specific novel miRNAs, i.e. those not pre-
viously recognized in any species, we required the existence
of both arms in the sequencing data to show perfect 2 nt 3’
overhangs as produced by Drosha/Dicer.
Validated and predicted gene targets
Genes that have been experimentally validated as functional
targets of the diff-reg miRNAs identified were retrieved
from the miRTarBase repository [67]. These were reviewed
by the authors to tag the ones salient to pain physiology.
For the 3 most abundantly expressed diff-reg miRNAs
identified we also searched TartgetScan [68] for gene
targets that are predicted based on their sequences,
but not (yet) documented experimentally, to be plausible
functional targets. These were further scanned for
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by uploading the targets of each of the 3 miRNAs inde-
pendently to WebGestalt (WEB-based GEne SeT AnaLysis
Toolkit) following all default parameters for the GO
analysis [69,70].
Additional file
Additional file 1: Table S1. Top 50 miRNAs ranked in order of
abundance in the L4 and 5 DRGs of sham operated rats. Table S2.
miRNAs nominally up- and down-regulated (p<0.05 before correction for
multiple testing) after SNL nerve injury in HA (n=23) and LA rats (n=35;
ranked by p-value). SNL-reg was calculated from RPM by the subtraction
method: (SNL-sham)/(SNL+sham). None showed significant SNL-reg after
FDR correction for multiple testing. Table S3. Top miRNAs ranked by
nominal (uncorrected) statistical significance of differential regulation
between HA and LA DRGs following SNL nerve injury (subtraction method,
HA_SNL1 pool excluded). miRNAs with significant diff-reg after FDR
correction (Table 1) are set in italics. Table S4. Top miRNAs ranked by
magnitude of differential regulation between HA and LA DRGs following
SNL nerve injury (subtraction method). Table S5.miRNAs identified in rat DRGs
that have not been previous reported in the rat (miRBase-v19). The ones with
the prefix rnoH have homologs of the same number in other species
(mostly the mouse). One was listed in the rat miRBase-v20. The ones numbered
X1, X2 do not have homologs in any other species (sequence noted).
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